Search research articles
Contact Us
Filters
Showing results (41-50 of 74) with videos related to
Page
of 8
Sort By:
Theranostics
|
January 6, 2022
Tumor-infiltrating lymphocytes are functionally inactivated by CD90+ stromal cells and reactivated by combined Ibrutinib and Rapamycin in human pleural mesothelioma
Haitang Yang, Sabina Berezowska, Patrick Dorn, et al.
European Journal of Radiology
|
May 29, 2024
Pneumothorax risk reduction during CT-guided lung biopsy - Effect of fluid application to the pleura before lung puncture and the gravitational effect of pleural pressure
Michael P Brönnimann, Andreas Christe, Johannes T Heverhagen, et al.
JTO Clinical and Research Reports
|
May 8, 2024
BAP1 Deficiency Inflames the Tumor Immune Microenvironment and Is a Candidate Biomarker for Immunotherapy Response in Malignant Pleural Mesothelioma
Duo Xu, Yanyun Gao, Haitang Yang, et al.
Tomography (Ann Arbor, Mich.)
|
March 26, 2025
Ground-Glass Opacities in the Access Route and Biopsy in Highly Perfused Dependent Areas of the Lungs as Risk Factors for Pulmonary Hemorrhage During CT-Guided Lung Biopsy: A Retrospective Study
Michael P Brönnimann, Leonie Manser, Andreas Christe, et al.
Scientific Reports
|
September 8, 2017
Increased PD-L1 expression and IL-6 secretion characterize human lung tumor-derived perivascular-like cells that promote vascular leakage in a perfusable microvasculature model
Colette A Bichsel, Limei Wang, Laurène Froment, et al.
Cancers
|
October 11, 2019
Endoplasmic Reticulum Stress Signaling as a Therapeutic Target in Malignant Pleural Mesothelioma
Duo Xu, Haitang Yang, Zhang Yang, et al.
Clinical and Translational Medicine
|
September 30, 2025
Distinct molecular subtypes of KRAS<sup>G12C</sup>-mutant lung adenocarcinoma: Insights into clinical outcomes, tumour microenvironments and therapeutic strategies
Haitang Yang, Anshun Zhu, Yongliang Niu, et al.
EMBO Molecular Medicine
|
July 24, 2025
De novo pyrimidine synthesis is a collateral metabolic vulnerability in NF2-deficient mesothelioma
Duo Xu, Yanyun Gao, Shengchen Liu, et al.
Ebiomedicine
|
November 5, 2021
Peritumoral CD90+CD73+ cells possess immunosuppressive features in human non-small cell lung cancer
Limei Wang, Haitang Yang, Patrick Dorn, et al.
The European Respiratory Journal
|
July 29, 2018
ERS/EACTS statement on the management of malignant pleural effusions
Anna C Bibby, Patrick Dorn, Ioannis Psallidas, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 74) with videos related to
Sort By:
Page
of 8
Theranostics
|
January 6, 2022
Tumor-infiltrating lymphocytes are functionally inactivated by CD90+ stromal cells and reactivated by combined Ibrutinib and Rapamycin in human pleural mesothelioma
Haitang Yang, Sabina Berezowska, Patrick Dorn, et al.
European Journal of Radiology
|
May 29, 2024
Pneumothorax risk reduction during CT-guided lung biopsy - Effect of fluid application to the pleura before lung puncture and the gravitational effect of pleural pressure
Michael P Brönnimann, Andreas Christe, Johannes T Heverhagen, et al.
JTO Clinical and Research Reports
|
May 8, 2024
BAP1 Deficiency Inflames the Tumor Immune Microenvironment and Is a Candidate Biomarker for Immunotherapy Response in Malignant Pleural Mesothelioma
Duo Xu, Yanyun Gao, Haitang Yang, et al.
Tomography (Ann Arbor, Mich.)
|
March 26, 2025
Ground-Glass Opacities in the Access Route and Biopsy in Highly Perfused Dependent Areas of the Lungs as Risk Factors for Pulmonary Hemorrhage During CT-Guided Lung Biopsy: A Retrospective Study
Michael P Brönnimann, Leonie Manser, Andreas Christe, et al.
Scientific Reports
|
September 8, 2017
Increased PD-L1 expression and IL-6 secretion characterize human lung tumor-derived perivascular-like cells that promote vascular leakage in a perfusable microvasculature model
Colette A Bichsel, Limei Wang, Laurène Froment, et al.
Cancers
|
October 11, 2019
Endoplasmic Reticulum Stress Signaling as a Therapeutic Target in Malignant Pleural Mesothelioma
Duo Xu, Haitang Yang, Zhang Yang, et al.
Clinical and Translational Medicine
|
September 30, 2025
Distinct molecular subtypes of KRAS<sup>G12C</sup>-mutant lung adenocarcinoma: Insights into clinical outcomes, tumour microenvironments and therapeutic strategies
Haitang Yang, Anshun Zhu, Yongliang Niu, et al.
EMBO Molecular Medicine
|
July 24, 2025
De novo pyrimidine synthesis is a collateral metabolic vulnerability in NF2-deficient mesothelioma
Duo Xu, Yanyun Gao, Shengchen Liu, et al.
Ebiomedicine
|
November 5, 2021
Peritumoral CD90+CD73+ cells possess immunosuppressive features in human non-small cell lung cancer
Limei Wang, Haitang Yang, Patrick Dorn, et al.
The European Respiratory Journal
|
July 29, 2018
ERS/EACTS statement on the management of malignant pleural effusions
Anna C Bibby, Patrick Dorn, Ioannis Psallidas, et al.
Page
of 8